Persistent Pessimism US Consumer Sentiment Remains Low Amid Inflation Geopolitical Tensions and Trade Policy Uncertainty General Motors Expands EV Lineup with Cadillac Vistiq Targeting 300Mile Range Karnataka Extends 2847 Crore Support as BengaluruBidar Kalaburagi Flights to Resume in June Flipkart Achieves Landmark 200 Million SingleDay Sales Milestone Serve Robotics SERV Oversold Status Raises Questions Among AI Investors Modine Manufacturing Reverses After PostEarnings Surge Data Center Demand in Focus ALNY Q1 2026 Earnings EPS Smashes Estimates While Shares Edge Lower RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction RF Q1 2026 Earnings Modest EPS Beat Amid Stable Performance NeoVolta Q1 2026 Earnings Narrower Loss Beats Expectations as Stock Rises Iveda Solutions IVDA Q2 2024 Earnings Narrower Loss Beats Expectations Despite Revenue Uncertainty KLIC Q1 2026 Earnings EPS Surpasses Estimates by 157 TruGolf Holdings TRUG Edges Higher as Stock Tests Resistance Near 162 Forgent Power Solutions Inc FPS Faces Resistance Slipping 128 Amid Cautious Trading FG Merger II Corp Rights FGMCR Edges Lower as Stock Tests Key Support Presidio Property Trust Series A SQFTW Trades Flat at 002 Amidst Thin Liquidity BTCS Inc Slides 273 as Key Support Levels Approached Stellantis Restructuring Prediction Market Oversight Oura IPO Lead Morning Market Briefing SPB Q1 2026 Earnings EPS Surpasses Estimates by 127 Stock Declines 14 Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support PTEN Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses EBAY Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations DH Q1 2026 Earnings EPS Surges 791 Above Estimates Stock Rises 39 PRME Q1 2026 Earnings EPS Worse Than Expected as PreRevenue Biotech Advances Pipeline Wells Fargo Q1 2026 Earnings Slight EPS Beat Amid Steady Operating Performance PALI Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges